The 3rd World Conference on Kisspeptin, “Kisspeptin 2017: Brain and Beyond”: Unresolved questions,challenges and future directions for the field |
| |
| Authors: | M. N. Lehman L. M. Coolen R. A. Steiner G. Neal‐Perry L. Wang S. M. Moenter A. M. Moore R. L. Goodman S.‐H. Yeo S. L. Padilla A. S. Kauffman J. Garcia M. J. Kelly J. Clarkson S. Radovick A. V. Babwah S. Leon M. Tena‐Sempere A. N. Comninos S. Seminara W. S. Dhillo J. Levine E. Terasawa A. Negron V. M. Navarro A. E. Herbison |
| |
| Affiliation: | 1. Department of Neurobiology and Anatomical Sciences, University of Mississippi Medical Center, Jackson, MS,, USA;2. Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, MS,, USA;3. Departments of Obstetrics and Gynecology and Physiology and Biophysics, University of Washington, Seattle, WA,, USA;4. Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI,, USA;5. Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI,, USA;6. Department of Internal Medicine, University of Michigan, Ann Arbor, MI,, USA;7. Department of Physiology, Pharmacology and Neuroscience, West Virginia University, Morgantown, WV,, USA;8. Reproductive Physiology Group, Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK;9. Howard Hughes Medical Institute, University of Washington, Seattle, WA, USA;10. Department of Obstetrics and Gynecology and Reproductive Sciences, University of California, San Diego, La Jolla, CA,, USA;11. Endocrinology and Reproductive Physiology Training Program, University of Wisconsin‐Madison, Madison, WI, USA;12. Department of Physiology and Pharmacology, Oregon Health and Science University, Portland, OR,, USA;13. Division of Neuroscience, Oregon National Primate Research Center, Beaverton, OR,, USA;14. Centre for Neuroendocrinology and Department of Physiology, University of Otago School of Biomedical Science, Dunedin, New Zealand;15. Department of Pediatrics, Rutgers University 16. – 17. Robert Wood Johnson Medical School, New Brunswick, NJ,, USA;18. Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA,, USA;19. Instituto Maimonides de Investigación Biomédica de Córdoba (IMIBIC), Cordoba, Spain;20. Department of Cell Biology, Physiology and Immunology, University of Córdoba, Cordoba, Spain;21. Hospital Universitario Reina Sofia, Cordoba, Spain;22. CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Córdoba, Spain;23. Section of Investigative Medicine, Imperial College London, Hammersmith Hospital, London, UK;24. Harvard Reproductive Sciences Center and Reproductive Endocrine Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA,, USA;25. Wisconsin National Primate Research Center, University of Wisconsin–Madison, Madison, WI,, USA;26. Department of Neuroscience, University of Wisconsin School of Medicine and Public Health, Madison, WI,, USA;27. Department of Pediatrics, University of Wisconsin–Madison, Madison, MA, USA;28. Division of Endocrinology, Diabetes and Hypertension. Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA |
| |
| Abstract: | The 3rd World Conference on Kisspeptin, “Kisspeptin 2017: Brain and Beyond” was held on 30‐31 March at the Rosen Centre Hotel in Orlando, Florida, providing an international forum for multidisciplinary scientists to meet and share cutting‐edge research on kisspeptin biology and its relevance to human health and disease. The meeting built upon previous world conferences focused on the role of kisspeptin and associated peptides in the control of gonadotrophin‐releasing hormone (GnRH) secretion and reproduction. Based on recent discoveries, the scope of this meeting was expanded to include functions of kisspeptin and related peptides in other physiological systems, including energy homeostasis, pregnancy, ovarian and uterine function, and thermoregulation. In addition, discussions addressed the translation of basic knowledge of kisspeptin biology to the treatment of disease, with the goal of seeking consensus about the best approaches to improve human health. The 2‐day meeting featured a nontraditional structure, with each day starting with poster sessions followed by lunch discussions and facilitated large‐group sessions with short presentations to maximise the exchange of new, unpublished data. Topics were identified by a survey prior to the meeting, and focused on major unresolved questions, important controversies and future directions in the field. Finally, career development activities provided mentoring for trainees and junior investigators, as well as networking opportunities for those individuals with established researchers in the field. Overall, the meeting was rated as a success by attendees and covered a wide range of lively and provocative discussion topics on the changing nature of the field of “kisspeptinology” and its future. |
| |
| Keywords: | conference GnRH international kisspeptin neuroendocrine |
|
|
